Condition
AIDS-Related Human Papillomavirus Infection
Total Trials
1
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Laboratory Biomarker Analysis
Research Leaders
7 sponsors active, led by AIDS and Cancer Specimen Resource
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 1 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
100%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
Phase 3 (1)
Trial Status
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Laboratory Biomarker Analysis1
- Saline1
Active Sponsors
- AIDS and Cancer Specimen Resource1
- National Cancer Institute (NCI)1
- University of Arkansas1
- AIDS Malignancy Consortium1
- Merck Sharp & Dohme LLC1
Top Investigators
University of Witwatersrand, South Africa
Related Conditions
- Hiv Infection1
- High Grade Cervical Squamous Intraepithelial Neoplasia1